An engineered IL-2 partial agonist promotes CD8+ T cell stemness DOI
Fei Mo, Zhiya Yu, Peng Li

et al.

Nature, Journal Year: 2021, Volume and Issue: 597(7877), P. 544 - 548

Published: Sept. 15, 2021

Language: Английский

Monocyte-derived IL-1 and IL-6 are differentially required for cytokine-release syndrome and neurotoxicity due to CAR T cells DOI

Margherita Norelli,

Barbara Camisa,

Giulia Barbiera

et al.

Nature Medicine, Journal Year: 2018, Volume and Issue: 24(6), P. 739 - 748

Published: May 24, 2018

Language: Английский

Citations

1168

From chemotherapy to biological therapy: A review of novel concepts to reduce the side effects of systemic cancer treatment (Review) DOI Creative Commons
Volker Schirrmacher

International Journal of Oncology, Journal Year: 2018, Volume and Issue: 54(2), P. 407 - 419

Published: Dec. 10, 2018

The side effects of systemic chemotherapy used to treat cancer are often severe. For decades, oncologists have focused on treating the tumor, which may result in damage tumor‑bearing host and its immune system. Recently, much attention has been paid system patients activation via biological therapies. Biological therapies, including immunotherapy oncolytic virus (OV) therapy, more physiological well tolerated. present review elucidated how these therapies work why be better tolerated: i) In contrast chemotherapy, immunotherapies induce a memory function adaptive immunity system; ii) aim specifically activate against cancer; low due tolerance mechanisms, maintain integrity body presence B T lymphocytes with their antigen‑receptor specificities and; iii) type I interferon response, is evoked by OVs, an ancient innate defense support system, therefore benefit treatment. immunotherapy, reducing increasing long‑lasting efficacy therapy.

Language: Английский

Citations

1104

Immunosenescence and Inflamm-Aging As Two Sides of the Same Coin: Friends or Foes? DOI Creative Commons
Tamàs Fülöp, Anis Larbi, Gilles Dupuis

et al.

Frontiers in Immunology, Journal Year: 2018, Volume and Issue: 8

Published: Jan. 9, 2018

The immune system is the most important protective physiological of organism. It has many connections with other systems and is, in fact, often considered as part larger neuro-endocrine-immune axis. Most experimental data on changes aging show a decline parameters when compared to young healthy subjects. bulk these termed immunosenescence. Immunosenescence been for some time detrimental because it leads subclinical accumulation proinflammatory factors inflamm-aging. Together, immunosenescence inflamm-aging are suggested stand at origin diseases elderly, such infections, cancer, autoimmune disorders, chronic inflammatory diseases. However, an increasing number immune-gerontologists have challenged this negative interpretation respect its significance aging-related alterations system. If one considers from evolutionary perspective, they can be viewed preferably adaptive or remodeling rather than solely detrimental. Whereas conceivable that global may lead various diseases, also obvious needed extended survival/longevity. Recent cumulative suggest that, without existence immunosenescence/inflamm-aging duo (representing two sides same phenomenon), human longevity would greatly shortened. This review summarizes recent dynamic reassessment aging. Accordingly, attempts intervene by targeting rejuvenation, more suitable aim maintain general homeostasis function appropriately improving immune-inflammatory-functions.

Language: Английский

Citations

1090

CAR T Cells for Solid Tumors: New Strategies for Finding, Infiltrating, and Surviving in the Tumor Microenvironment DOI Creative Commons
Marina C. Martinez, Edmund K. Moon

Frontiers in Immunology, Journal Year: 2019, Volume and Issue: 10

Published: Feb. 4, 2019

Chimeric antigen receptor (CAR) T cells, cells that have been genetically engineered to express a recognizes specific antigen, given rise breakthroughs in treating hematological malignancies. However, their success solid tumors has limited. The unique challenges posed CAR cell therapy by can be described three steps: finding, entering, and surviving the tumor. use of dual designs recognize multiple antigens at once local administration are both strategies used overcome hurdle localization Additionally, immunosuppressive tumor microenvironment implications for function terms differentiation exhaustion, combining CARs with checkpoint blockade or depletion other suppressive factors shown very promising results mitigate phenomenon exhaustion. Finally, identifying overcoming mechanisms associated dysfunction is vital importance generating proliferate successfully eliminate cells. structure costimulatory domains chosen may play an important role overall TME, "armored" secrete cytokines third- fourth-generation offer ways enhance function.

Language: Английский

Citations

734

B cell maturation antigen–specific CAR T cells are clinically active in multiple myeloma DOI Open Access
Adam D. Cohen, Alfred L. Garfall, Edward A. Stadtmauer

et al.

Journal of Clinical Investigation, Journal Year: 2019, Volume and Issue: 129(6), P. 2210 - 2221

Published: March 21, 2019

BACKGROUND. CAR T cells are a promising therapy for hematologic malignancies. B cell maturation antigen (BCMA) is rational target in multiple myeloma (MM).

Language: Английский

Citations

655

Tumor-infiltrating lymphocytes in the immunotherapy era DOI Open Access

Sterre T. Paijens,

Annegé Vledder, Marco de Bruyn

et al.

Cellular and Molecular Immunology, Journal Year: 2020, Volume and Issue: 18(4), P. 842 - 859

Published: Nov. 2, 2020

Language: Английский

Citations

651

Single-cell RNA-seq reveals TOX as a key regulator of CD8+ T cell persistence in chronic infection DOI
Chen Yao, Hong‐Wei Sun, Neal E. Lacey

et al.

Nature Immunology, Journal Year: 2019, Volume and Issue: 20(7), P. 890 - 901

Published: June 17, 2019

Language: Английский

Citations

466

Personal neoantigen vaccines induce persistent memory T cell responses and epitope spreading in patients with melanoma DOI

Zhuting Hu,

Donna Leet, Rosa Lundbye Allesøe

et al.

Nature Medicine, Journal Year: 2021, Volume and Issue: 27(3), P. 515 - 525

Published: Jan. 21, 2021

Language: Английский

Citations

390

Discriminating mild from critical COVID-19 by innate and adaptive immune single-cell profiling of bronchoalveolar lavages DOI Creative Commons
Els Wauters, Pierre Van Mol, Abhishek D. Garg

et al.

Cell Research, Journal Year: 2021, Volume and Issue: 31(3), P. 272 - 290

Published: Jan. 21, 2021

Abstract How the innate and adaptive host immune system miscommunicate to worsen COVID-19 immunopathology has not been fully elucidated. Here, we perform single-cell deep-immune profiling of bronchoalveolar lavage (BAL) samples from 5 patients with mild 26 critical in comparison BALs non-COVID-19 pneumonia normal lung. We use pseudotime inference build T-cell monocyte-to-macrophage trajectories model gene expression changes along them. In COVID-19, CD8 + resident-memory (T RM ) CD4 T-helper-17 H17 cells undergo active (presumably antigen-driven) expansion towards end trajectory, are characterized by good effector functions, while they remain more naïve. Vice versa, T-cells T-helper-1 characteristics H1 -like) expressing exhaustion markers EX enriched halfway their where also exhibit show evidence inflammation-associated stress at trajectories. Monocyte-to-macrophage that chronic hyperinflammatory monocytes alveolar macrophages, otherwise anti-inflammatory antigen-presenting characteristics, depleted. contribute an ATP-purinergic signaling-inflammasome footprint could enable associated fibrosis disease-severity. Finally, viral RNA-tracking reveals infected lung epithelial cells, a significant proportion neutrophils macrophages involved clearance.

Language: Английский

Citations

330

The integration of inflammaging in age-related diseases DOI
Tamàs Fülöp, Jacek M. Witkowski, Fabiola Olivieri

et al.

Seminars in Immunology, Journal Year: 2018, Volume and Issue: 40, P. 17 - 35

Published: Oct. 2, 2018

Language: Английский

Citations

289